Similar articles

• Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy?

  Burness ML, Olopade OI. Burness ML, et al. J Clin Oncol. 2011 May 1;29(13):1652-4. doi: 10.1200/JCO.2010.32.5274. Epub 2011 Mar 28. J Clin Oncol. 2011. PMID: 21444875 No abstract available.
• Perspectives in the clinical management of BRCA mutations carriers.

  Savarese A, Cognetti F. Savarese A, et al. J Exp Clin Cancer Res. 2002 Sep;21(3 Suppl):31-5. J Exp Clin Cancer Res. 2002. PMID: 12585651 Review.
• Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.

  Pierce L. Pierce L. Semin Radiat Oncol. 2002 Oct;12(4):352-61. doi: 10.1053/srao.2002.35254. Semin Radiat Oncol. 2002. PMID: 12382193 Review.
• Prophylactic mastectomy in carriers of BRCA mutations.

  Riggs T. Riggs T. N Engl J Med. 2001 Nov 15;345(20):1499; author reply 1499-500. N Engl J Med. 2001. PMID: 11794205 No abstract available.
• Prophylactic mastectomy in carriers of BRCA mutations.

  Narod S. Narod S. N Engl J Med. 2001 Nov 15;345(20):1498; author reply 1499-500. N Engl J Med. 2001. PMID: 11794204 No abstract available.